Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-I and IGFBP-3 measurements
Body composition research: The peptide is used in models exploring visceral adiposity, metabolic efficiency, and weight-related endpoints in obese phenotypes and diet-induced obesity rodents
In comparison, research shows that Orlistat supports 4-8% weight loss, suggesting that, on average, Wegovy leads to at least 10% more weight loss than Orlistat over a year
10.1093/eurheartj/ehw582 27
The simplicity is intentional: the fewer inactive ingredients in the diluent, the lower the risk of interaction with whatever medication is being reconstituted
If you suspect you may have insulin resistance or are managing blood sugar, understanding your GLP-1 pathway is one of the most important first steps you can take